MARKET

APOP

APOP

Cellect Bio
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.920
-0.130
-4.26%
After Hours: 2.910 -0.01 -0.34% 19:59 04/09 EDT
OPEN
3.000
PREV CLOSE
3.050
HIGH
3.004
LOW
2.880
VOLUME
125.93K
TURNOVER
--
52 WEEK HIGH
7.15
52 WEEK LOW
1.650
MARKET CAP
11.42M
P/E (TTM)
--
1D
5D
1M
3M
1Y
5Y
Cellect Biotechnology reports Q4 results
Cellect Biotechnology (APOP): Q4 GAAP EPS of NIS0.01.Cash and cash equivalents of NIS16.96MPress Release
Seekingalpha · 03/29 13:45
Cellect Biotechnology Reports Fourth Quarter and Full Year 2020 Financial and Operating Results
Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology that enables the functional selection of stem cells, today reported financial and operating results for the fourth quarter and full year ended December 31, 2020 and provided ...
GlobeNewswire · 03/29 13:29
-- Earnings Flash (APOP) CELLECT BIOTECHNOLOGY Reports Q4 Loss $-0.01
MT Newswires · 03/29 09:46
Mid-Morning Market Update: Markets Open Higher; Madison Square Garden To Acquire MSG Networks
  Following the market opening Friday, the Dow traded up 0.54% to 32,795.18 while the NASDAQ rose 0.49% to 13,040.76. The S&P also rose, gaining 0.55% to 3,930.83.
Benzinga · 03/26 14:38
NIO, TAL Education among premarket losers' pack
HighPoint Resources (HPR) -17%.Vuzix (VUZI) -16% on pricing $85M stock offering.Cellect Biotechnology (APOP) -12%GAN (GAN) -10% on Q4 earnings release.Hall of Fame Resort & Entertainment (HOFV) -9%.Cinedigm (CIDM) -8%.Co-Diagnostics (CODX) -8% on FY earnin...
Seekingalpha · 03/26 12:20
The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 25)
Benzinga · 03/26 11:28
Mid-Afternoon Market Update: Dow Rises 75 Points; Rite Aid Shares Plummet
Toward the end of trading Thursday, the Dow traded up 0.23% to 32,495 while the NASDAQ fell 0.37% to 12,913.99. The S&P also rose, gaining 0.13% to 3,894.05.
Benzinga · 03/25 18:39
GME, RAD, CIDM and EVFM among midday movers
Gainers: ProQR Therapeutics (PRQR) +47%.Cellect Biotechnology (APOP) +47%.Houston Wire & Cable (HWCC) +38%.GameStop (GME) +29%.Koss (KOSS) +28%.Cinedigm (CIDM) +28%.F-star Therapeutics (FSTX) +26%.FreightCar America (RAIL) +24%.Polar Power (POLA) +20%.Immu...
Seekingalpha · 03/25 16:40
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Balance SheetMore
Cash FlowMore
Learn about the latest financial forecast of APOP. Analyze the recent business situations of Cellect Bio through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average APOP stock price target is 12.00 with a high estimate of 12.00 and a low estimate of 12.00.
EPS
Institutional Holdings
Institutions: 11
Institutional Holdings: 589.62K
% Owned: 15.08%
Shares Outstanding: 3.91M
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
1
74.17K
Sold Out
4
83.26K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-0.53%
Pharmaceuticals & Medical Research
+0.26%
Key Executives
Chairman/Director
Nuriel Kasbian
Chief Executive Officer/Director
Shai Yarkoni
Chief Financial Officer
Eyal Leibovitz
Vice President - Research & Development
Amotz Nehushtan
Other
Yaron Pereg
Other
Guy Sapir
Director
Ruth Ben Yakar
Director
Michael Berelowitz
Non-Executive Director
Yuval Berman
Non-Executive Director
David Grossman
Independent Director
Abraham Nahmias
No Data
About APOP
Cellect Biotechnology Ltd is an Israel-based biotechnology company. Its technology platform, ApoGraft, selects stem cells to improve the safety and efficacy of regenerative medicine and cell therapies by using functional selection. Efficient selection enables retention of most of the stem cells while neutralizing harmful mature cells. ApoGraft exploit a functional characteristic of stem cells relating to apoptosis, which is the process of programmed cell death and is a vital part of physiological development and homeostasis of all organisms. Stem cells flourish in an environment where normal cells die because their main role is reconstitution of damaged tissue. The platform is being tested for clinical use in allogeneic hematopoietic stem cell transplantation (HSCT) for the treatment of hematological malignancies. Additionally, the Company is developing its first product based on its platform, the ApoTainer selection kit that utilizes FasL-coated paramagnetic beads.

Webull offers kinds of Cellect Biotechnology Ltd - ADR stock information, including NASDAQ:APOP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APOP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading APOP stock methods without spending real money on the virtual paper trading platform.